- Uburyo bwo kuvura
- Ubuhamya
- Neuroblastoma
- Indwara ikomeye
- Ubuhamya
- TILS
- Ubuvuzi bwa Selile za NK
- Myasthenia Gravis (MG)
- Leukemia ikabije ya Lymphoblastic (B-ALL)
- Indwara ya Lupus Erythematosus yo mu mubiri (SLE)
- Leukemia ikabije ya Lymphoblastic (T-ALL)
- Lymphoma itari iya Hodgkin (NHL)
- Myeloma nyinshi (MM)
- Lymphom nini ya B-cell ikwirakwira
- Leukemia ya B-lymphocytic
- Myeloma
Intsinzi ya Madhavan: Gutsinda Glioma yo mu bwonko hakoreshejwe Bioocus B7H3 CAR-T Therapy
Amavuriro y'umurwayi
Madhavan yapimwe indwara ya glioma yo mu bwonko, ikibyimba kibi kizwiho kuba cyarangiritse kandi kikaba kitaragaragara neza. Ku myaka 58, nyuma y’uko ubuvuzi busanzwe burimo kubagwa no kunanirwa kw’imirasire, yerekeje kuri Bioocus kugira ngo ahabwe amahitamo agezweho. Yoherejwe mu bitaro bya Tianjin Tumor Hospital Konggang, yiyandikishije muri gahunda yacu ya B7H3 CAR-T ku buvuzi nimero P001. B7H3 igaragara cyane ku turemangingo twa glioma, bigatuma iba intego nziza ku turemangingo twa T twakozwe hifashishijwe amazi yo mu bwonko (CSF) kugira ngo twibasire iki kibyimba.
Urugendo rw'Ubuvuzi
Ubuvuzi bwa Madhavan bwasabaga gushyira uturemangingo twa CAR-T mu bwoko bwa CSF, hagakurikiranwa hakoreshejwe isesengura rya CSF kuva ku munsi wa 2 (D2) kugeza ku munsi wa 28 (D28).
- D2 (8 Kanama 2025):Imbere hagaragara cyane B7H3 CAR-T kuri 54.44% by'uturemangingo twa CD3+ T.
- D4 (Ku ya 11 Kanama 2025):52%, bigaragaza imiterere ya mbere.
- D7 (Ku ya 14 Kanama 2025):Yazamutse igera kuri 59.51%.
- D10 (Ku ya 17 Kanama 2025):12%.
- D14 (Ku ya 21 Kanama 2025):19%.
- D21 (Ku ya 28 Kanama 2025):Yageze ku kigero cya 89.69%, igaragaza ko yagutse cyane.
- D28 (Ku ya 6 Nzeri 2025):Yahagaze neza kuri 13.58% by'uturemangingo twa CD3+ T, aho 11.90% muri CD4+ na 14.28% muri CD8+. Muri rusange, uturemangingo twa CD3+ T twiganje kuri 95.34%, aho CD8+ nyinshi (66.74%) zigaragaza uburozi bukomeye.
Imbonerahamwe z’impinduka zerekana ko CAR-T ikomeza guhindagurika ariko muri rusange ikaba ikomeye, ari ingenzi mu kurwanya ikibyimba mu mitsi mito.
Ibisubizo by'indashyikirwa
Kwaguka cyane kwa D21 byafitanye isano no kugabanuka kwa kanseri kuri MRI, bigatuma D28 ikira neza kandi igakomeza gutera imbere. Uku gutanga imiti mu mubiri bigabanya ingaruka mbi ku mubiri mu gihe birushaho kugira ingaruka nziza ku ndwara ya glioma, aho amakuru yacu agaragaza ko ubuzima bukomeza kuba bwiza kandi budafite ingaruka mbi. Madhavan yavuze ko ibimenyetso bishobora gukemuka kandi nta burozi bukomeye bw'ubwonko butera.
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

